7 claim verifications about United States United States ×
“Ultra-processed foods account for the majority of calories consumed by American adults as of March 2026.”
The claim is well-supported. A 2025 CDC report found American adults consumed 53% of their calories from ultra-processed foods during 2021–2023, and peer-reviewed research consistently places the figure above 50%. However, the most recent primary data doesn't extend to March 2026 specifically — it's an extrapolation from a 2021–2023 survey window. No evidence suggests the trend has reversed below the majority threshold, but the "as of March 2026" framing implies more current measurement than exists.
“Countries with universal healthcare systems have worse overall health outcomes compared to the United States.”
This claim is the opposite of what the evidence shows. Multiple high-authority sources—including the Peterson-KFF Health System Tracker, KFF, and America's Health Rankings—consistently demonstrate that countries with universal healthcare outperform the U.S. on life expectancy (by 4+ years), infant mortality, maternal mortality, and avoidable deaths. The U.S. spends far more per capita than any peer nation yet ranks last or near-last on most key health outcome measures. Avoidable deaths are rising in the U.S. while falling in universal-care nations.
“The average American household spends more per month on cable TV and streaming subscriptions combined than on groceries.”
This claim is false. BLS-based data consistently shows the average American household spends roughly $504–$519 per month on groceries. Combined cable TV and streaming costs top out at approximately $153–$278 per month — less than half the grocery bill. The higher "media spending" figures sometimes cited (~$280/month) include internet and mobile services, not just cable and streaming. Even using the most generous estimates, cable plus streaming doesn't come close to matching grocery expenditures for the average household.
“Ozempic and similar GLP-1 drugs have contributed to a reduction in United States obesity rates for the first time in decades.”
U.S. adult obesity rates have indeed declined modestly — from roughly 42.8% (2017–2018) to about 40.3% (2021–2023) per CDC data, with Gallup surveys showing a further drop to ~37% by 2025. This coincides with a dramatic surge in GLP-1 drug use (30+ million Americans by 2025). Experts widely identify GLP-1 drugs as a plausible contributing factor, but no study has confirmed a direct causal link at the population level. The decline is also uneven — rural obesity actually rose — and other factors like post-COVID behavioral changes haven't been ruled out.
“The Born In America Act prevents naturalized citizens from holding public office in the United States.”
No enacted law called the "Born in America Act" prevents naturalized citizens from holding public office. The viral claim that the U.S. Senate passed such legislation was debunked as fabricated (Snopes, November 2025). Under the Constitution, naturalized citizens are eligible for most federal offices, including Congress. Only the presidency requires "natural born" citizen status. This claim is false.
“Adverse possession laws in the United States allow a person to gain legal ownership of property by occupying it without permission for a statutory period.”
The claim is broadly accurate. U.S. adverse possession laws do allow a person to gain legal ownership of property by occupying it without the owner's permission for a state-defined statutory period. However, the claim simplifies the doctrine: courts also require that possession be open and notorious, exclusive, and continuous — and some states impose additional conditions like paying property taxes. Statutory periods vary widely (5–30 years) across jurisdictions. The core proposition is correct, but the framing omits important legal requirements.
“China's gross domestic product (GDP) will exceed that of the United States by the year 2030.”
This claim is not supported by current evidence. As of 2026, the US nominal GDP (~$31.8T) exceeds China's (~$20.7T) by over $11 trillion — a gap that cannot close by 2030 at projected growth rates. The major institutions once cited for a 2030 overtake (notably CEBR) have revised their forecasts to the mid-2030s. Goldman Sachs, Citi, and CEBR now all project the overtaking around 2035–2036. China also faces structural headwinds including a shrinking workforce and declining productivity growth.